Anti-citrullinated-protein-antibody-specific intravenous immunoglobulin attenuates collagen-induced arthritis in mice

The role of intravenous immunoglobulins in the treatment of rheumatoid arthritis

(2015) Nurit Katz-Agranov et al.   AUTOIMMUNITY REVIEWS

MRI assessment of suppression of structural damage in patients with rheumatoid arthritis receiving rituximab: results from the randomised, placebo-controlled, double-blind RA-SCORE study

(2014) Charles Peterfy et al.   ANNALS OF THE RHEUMATIC DISEASES

Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: Results from the GISEA register

(2014) Marco Sebastiani et al.   JOINT BONE SPINE

Longterm Followup of Rituximab Therapy in Patients with Rheumatoid Arthritis: Results from the Belgian MabThera in Rheumatoid Arthritis Registry

(2014) F. De Keyser et al.   JOURNAL OF RHEUMATOLOGY

Efficacy and Safety of Rituximab in Elderly Patients With Rheumatoid Arthritis Enrolled in a French Society of Rheumatology Registry

(2014) Sarah Payet et al.   ARTHRITIS CARE & RESEARCH

Enhanced neutrophil extracellular trap generation in rheumatoid arthritis: analysis of underlying signal transduction pathways and potential diagnostic utility

(2014) Chanchal Sur Chowdhury et al.   ARTHRITIS RESEARCH & THERAPY

Intravenous Immunoglobulin Attenuates Experimental Autoimmune Arthritis by Inducing Reciprocal Regulation of Th17 and Treg Cells in an Interleukin-10-Dependent Manner

(2014) Seon-Yeong Lee et al.   Arthritis & Rheumatology

Epitope Predictions Indicate the Presence of Two Distinct Types of Epitope-Antibody-Reactivities Determined by Epitope Profiling of Intravenous Immunoglobulins

(2013) Mitja Luštrek et al.   PLoS One

The Advantage of Specific Intravenous Immunoglobulin (sIVIG) on Regular IVIG: Experience of the Last Decade

(2012) Nina Svetlicky et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Update on Intravenous Immunoglobulins (IVIg) Mechanisms of Action and Off- Label use in Autoimmune Diseases

(2011) Uriel Katz et al.   CURRENT PHARMACEUTICAL DESIGN

Efficacy of intravenous immunoglobulin (IVIG) affinity-purified anti-desmoglein anti-idiotypic antibodies in the treatment of an experimental model of pemphigus vulgaris

(2010) D. Mimouni et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Immunomodulation by Intravenous Immunoglobulin: Role of Regulatory T Cells

(2010) Mohan S. Maddur et al.   JOURNAL OF CLINICAL IMMUNOLOGY

A Novel Role for the IgG Fc Glycan: The Anti-inflammatory Activity of Sialylated IgG Fcs

(2010) Robert M. Anthony et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Anti-cyclic citrullinated peptide antibodies from rheumatoid arthritis patients activate complement via both the classical and alternative pathways

(2009) L. A. Trouw et al.   ARTHRITIS AND RHEUMATISM

Evidence for the Use of Intravenous Immunoglobulins—A Review of the Literature

(2009) Shaye Kivity et al.   CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY

Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis

(2009) Natalia Wegner et al.   IMMUNOLOGICAL REVIEWS

Structure and pathogenicity of antibodies specific for citrullinated collagen type II in experimental arthritis

(2009) Hüseyin Uysal et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Induction of macrophage secretion of tumor necrosis factor α through Fcγ receptor IIa engagement by rheumatoid arthritis–specific autoantibodies to citrullinated proteins complexed with fibrinogen

(2008) Cyril Clavel et al.   ARTHRITIS AND RHEUMATISM

A disease-specific fraction isolated from IVIG is essential for the immunosuppressive effect of IVIG in experimental autoimmune myasthenia gravis

(2008) Sara Fuchs et al.   JOURNAL OF NEUROIMMUNOLOGY

Modulation of the cellular immune system by intravenous immunoglobulin

(2008) Thanyalak Tha-In et al.   TRENDS IN IMMUNOLOGY